PepTivator® WT1, human

PepTivator® WT1 is a pool of lyophilized peptides, consisting mainly of 15-mer sequences with 11 amino acids overlap, covering the complete sequence of the WT1 protein (UniProt ID: P19544).

PepTivator peptide pools have been developed for the efficient in vitro stimulation of antigen–specific T cells, as peptides of 15 amino acids in length and 11 amino acids overlap represent an optimized solution for stimulating both CD4+ and CD8+ T cells in various applications.

Quantitative, phenotypical, or functional analysis of WT1–specific T cell i

... read more
Choose your product:

Related products for PepTivator® WT1, human

Specifications for PepTivator® WT1, human
Overview

PepTivator® WT1 is a pool of lyophilized peptides, consisting mainly of 15-mer sequences with 11 amino acids overlap, covering the complete sequence of the WT1 protein (UniProt ID: P19544).

PepTivator peptide pools have been developed for the efficient in vitro stimulation of antigen–specific T cells, as peptides of 15 amino acids in length and 11 amino acids overlap represent an optimized solution for stimulating both CD4+ and CD8+ T cells in various applications.

Quantitative, phenotypical, or functional analysis of WT1–specific T cell immunity can provide important information on the natural course of immune responses.

Detailed product information
Background information

Wilms tumor 1 (WT1), a zinc-finger transcription factor, is expressed during normal ontogenesis. Expression is absent or restricted to a very low level in adult healthy tissue. The WT1 protein is abundantly found in various types of hematological maligancies and solid tumors. It is a key molecule for tumor proliferation, inducing spontaneous humoral and cytotoxic T cell responses, and has become an attractive target for anticancer immunotherapy.

Downstream applications

The in vitro stimulation of WT1–specific T cells with PepTivator WT1 causes the secretion of effector cytokines and the up-regulation of activation markers, which then allow the detection and isolation of WT1–specific T cells.

  • Detection and analysis of WT1–specific CD4+ and CD8+ effector/memory T cells in PBMCs by MACS® Cytokine Secretion Assays, intracellular cytokine staining, or other technologies.
  • Isolation of viable WT1–specific CD4+ T cells with the CD154 MicroBead Kit, or of CD4+ and CD8+ T cells using the CD137 MicroBead Kit or MACS Cytokine Secretion Assay – Cell Enrichment and Detection Kits. Subsequently, cells can be expanded for generation of T cell lines for research on immunotherapy.
  • Generation of WT1–specific CD4+ and CD8+ effector/memory T cells from naive T cell populations for research on immunotherapy and vaccination.
  • Pulsing of antigen-presenting cells for research on dendritic cell vaccination.
Resources for PepTivator® WT1, human
Documents and Protocols

You have previously chosen International as your location.
What do you want to do?